세계의 광견병 진단 시장 - 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Global Rabies Diagnostics Market is poised to expand at a 4.7% CAGR between 2024 and 2032, fueled by the increasing demand for reliable and accurate diagnostic methods. Rabies, a fatal viral disease, continues to pose significant public health challenges, particularly in low- and middle-income countries. The World Health Organization (WHO) reports that rabies leads to tens of thousands of fatalities annually, with the majority occurring in Asia and Africa. With the growing focus on early and accurate disease detection, the adoption of advanced rabies diagnostics will rise significantly, supporting market growth.

The overall rabies diagnostics industry is categorized based on Test Type, Technology, Sample Type, End-use, and Region.

The chromatography segment will capture a significant share of the rabies diagnostics market by 2032. Chromatography technology is gaining prominence in rabies diagnostics due to its ability to deliver precise and rapid results. This technology enables the separation and analysis of complex biological samples, making it a preferred choice for rabies detection. The increasing prevalence of rabies in various regions, coupled with the need for advanced diagnostic techniques, is driving the adoption of chromatography in rabies diagnostics. Furthermore, ongoing technological advancements and innovations in chromatography will enhance the efficiency and accuracy of rabies testing.

The diagnostic laboratories segment will grow substantially over the forecast period. Diagnostic laboratories play a crucial role in the early detection and management of rabies, offering specialized testing services that ensure accurate and timely diagnosis. The rising incidence of rabies, particularly in endemic regions, has led to an increased demand for diagnostic services, thereby driving the growth of this segment. Additionally, the expanding laboratory networks and the implementation of stringent quality control measures contribute to the growing reliance on diagnostic laboratories for rabies testing. This trend will continue as the need for reliable and standardized diagnostic services intensifies.

Europe rabies diagnostics market will achieve commendable growth through 2024-2032, supported by a robust healthcare infrastructure, substantial investment in research and development, and a high level of public awareness regarding rabies prevention and control. The region's well-established diagnostic facilities and strong regulatory frameworks ensure the quality and reliability of diagnostic tests. Moreover, government initiatives aimed at eradicating rabies and the presence of leading diagnostic companies in Europe are further driving innovation and market expansion. As a result, Europe will remain a key region for rabies diagnostics, contributing significantly to global market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising cases of animal bites
    • 3.2.1.2 Increasing prevalence of neglected tropical diseases (NTDS)
    • 3.2.1.3 Technological advancements in diagnostics
    • 3.2.1.4 Favorable government policies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of test
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Fluorescent antibody test (FAT)
• 5.3 Immunohistochemical test
• 5.4 Amplification methods
• 5.5 Histologic examination
• 5.6 Serology tests

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 ELISA
• 6.3 Chromatography
• 6.4 PCR
• 6.5 Other techniques

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Brain tissue
• 7.3 Saliva
• 7.4 Cerebrospinal fluid (CSF)
• 7.5 Blood (Serum)
• 7.6 Other sample types

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbexa Ltd
• 10.2 Aviva Systems Biology Corporation
• 10.3 BIONOTE Co., LTD
• 10.4 Bio-Rad Laboratories, Inc.
• 10.5 Creative Diagnostics
• 10.6 Demeditec Diagnostics GmbH
• 10.7 Merck KGaA
• 10.8 MyBioSource, Inc.
• 10.9 Norgen Biotek Corp.
• 10.10 Thermo Fisher Scientific Inc.